Evidence map›Paper›PMID 31288262›Full record

ReviewFrontline gastroenterology2019

Diagnosis and management of IgG4-related disease.

Vinod S Hegade, Maria B Sheridan, Matthew T Huggett

Abstract readReview
In one paragraph

Review in Frontline gastroenterology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. [Immunoglobulin G4 disease with pancreatic affectation: the mimicker of malignancy].Revista medica del Instituto Mexicano del Seguro Social · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Modern imaging of cholangitis.The British journal of radiology · 2021
    Review
  15. Article
  16. Early pancreatic cancer in IgG4-related pancreatic mass: A case report.World journal of gastrointestinal surgery · 2019
    Article
  17. Article
  18. Progressing pancreaticobiliary medicine in the UK.Frontline gastroenterology · 2019
    Article
  19. Immunoglobulin G subclass 4-related disease of the lacrimal sac presenting as bilateral lacrimal sac nodules: Rare case report.Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Vinod S HegadeDepartment of Gastroenterology, St James University Hospital, Leeds, UK.ORCID 0000-0001-9572-2361
Maria B SheridanDepartment of Radiology, St James University Hospital, Leeds, UK.
Matthew T HuggettDepartment of Gastroenterology, St James University Hospital, Leeds, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IgG subclass 4-related disease (IgG4-RD) is a rare but increasingly recognised fibroinflammatory condition known to affect multiple organs. IgG4-RD is characterised by unique histological features of lymphoplasmacytic infiltration, storiform fibrosis and obliterative phlebitis. In this review we describe the pancreaticobiliary manifestations of IgG4-RD, with particular emphasis on type 1 autoimmune pancreatitis (AIP) and IgG4-related sclerosing cholangitis (IgG4-SC). AIP and IgG4-SC can pose diagnostic challenges to the clinician as they may mimic pancreatic cancer and primary sclerosing cholangitis, respectively. We discuss current knowledge, clinical diagnostic criteria and recent advances and summarise the evidence base for current therapeutic approaches for AIP and IgG4-SC.

Indexed as

pancreaspancreatic diseasepancreatic fibrosispancreatic pathologypancreatitis

Identifiers

PMID31288262
PMCPMC6583577

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.